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  Calbindin-D9k (CaBP-9k) is a cytosolic calcium-binding 
protein expressed in tissues in the intestine, uterus, placenta, 
kidney,  pituitary  gland  and  bone.  Its  exact  function  is 
unknown, but it is considered to regulate intracytoplasmic 
concentration and transport of free ions (Ca
2+). CaBP-9k 
protein is involved in intestinal calcium absorption in the 
intestine and in the regulation of myometrial activity by 
intracellular calcium in the uterus. Renal CaBP-9k protein 
is  expressed  at  the  site  of  calcium  re-absorption  in  the 
kidney and expressed in distal convoluted tubules, where 
it is thought to facilitate calcium re-absorption. Expression 
of the CaBP-9k gene has been explored in most mammalians 
except  in  a  canine  model.  Presently,  we  elucidated  the 
expression of CaBP-9k mRNA and protein in the duodenum, 
kidney and uterus in a canine model involving two adult 
(2.5-year-old) female beagles. To collect tissues, the dogs 
were euthanized and then the abdominal cavity was exposed 
by  midline  incision.  The  proximal  duodenum,  cortex  of 
kidney  and  uterine  horn  were  collected.  Expression  of 
CaBP-9k mRNA was confirmed by reverse transcription- 
polymerase chain reaction (RT-PCR) and real-time PCR. 
CaBP-9k protein expression and localization were ascertained 
by  Western  blot  analysis  and  immunohistochemistry, 
respectively. CaBP-9k mRNA was detected in the duodenum, 
but not in the kidney and uterus. Its protein was expressed 
only in the enterocytes of the duodenum. Taken together, 
the results indicate that CaBP-9k mRNA and protein are 
highly expressed in the enterocytes of the duodenum of a 
canine model, consistent with findings in other mammalian 
species.
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Introduction
Calcium (Ca
2+) elicits activation of complex intracellular 
signaling cascades and intracellular messengers. Cytosolic- 
free Ca
2+ is crucial role in maintaining living organs and 
tissues, however, the mechanisms that couple membrane 
receptor activation to Ca
2+ signaling, and the pathways of 
Ca
2+ entry into the cytosol are only partly understood 
[6,28]. A 9-kilodalton cytosolic calcium-binding protein 
termed calbindin-D9k (CaBP-9k), which has two Ca
2+ 
binding domains, belongs to a family of intracellular proteins 
that display high affinities for Ca
2+ [8]. Full-length cDNA 
encoding human CaBP-9k has been cloned using reverse 
transcription-polymerase chain reaction (RT-PCR), which 
includes a coding region of 79 amino acids, a non-coding 
region comprising 57 5´ nucleotides and 159 3´ nucleotides, 
and a poly(A) tail, for a total length of 600 nucleotides [17]. 
Furthermore, the latter report revealed that this gene spans 
about 5.5-kb and is localized on the X-chromosome, 
consists of three exons, and carries four Alu repeats [18]. 
CaBP-9k is expressed in a variety of mammalian tissues, 
including tissues in the uterus, placenta, intestine, kidney, 
pituitary gland, and bone [1,25,26,33]. Research concerning 
the function of the calbindins suggests that calbindins 
participate in the process of Ca
2+ transport across cellular 
barriers [38]. 
In the duodenum, the functional role of CaBP-9k appears 
to be involved in intestinal calcium absorption and its gene 
is regulated at the transcriptional or post-transcriptional 
level by 1, 25-dihydroxyvitamin D3 (1,25-(OH)2D3), a 
hormonal form of vitamin D [10,39]. They represent 2-3% 
of the total proteins in enterocytes (the major epithelial cell 
type of the duodenal mucosa), where active Ca
2+ transport 
occurs [39]. In the kidney, CaBP-9k is expressed in the distal 
convoluted tubules, where it is thought to facilitate calcium 
re-absorption [30]. In addition, uterine CaBP-9k may be 
involved in controlling myometrial activity related with 
intracellular Ca
2+ level [26], but its exact role is still unclear. 16    Ji-Young Sim et al.
Uterine CaBP-9k is mainly expressed in myometrial and 
endometrial stromal cells in nonpregnant rats, but not in the 
luminal epithelial cells, while CaBP-9k expression is 
detected predominantly in luminal uterine epithelial cells in 
pregnant rats [4,10,11,29]. Interestingly, uterine CaBP-9k is 
not regulated by vitamin D despite the presence of vitamin 
D receptors in this tissue. Rather, regulation of CaBP-9k may 
be under the control of sex steroid hormones [9,11,20-22].
The expression of the CaBP-9k gene has been explored in 
most mammalians except canines. The present study was 
undertaken to elucidate the expression of CaBP-9k mRNA 
in the uterus, duodenum, and kidney of beagles by RT-PCR 
and real-time PCR. In addition, the protein expression and 
localization of CaBP-9k were examined in these tissues by 
Western blot analysis and immunohistochemistry, respectively.
Materials and Methods
Experimental animals and treatments
The experiments were performed using two 2.5-year-old 
female beagle dogs. Both dogs were individually housed in 
a polycarbonate cage with alternating 12 h light/dark cycles 
in an environmentally controlled room (temperature: 23 ± 
2
oC relative humidity: 50 ± 10%, frequent ventilation). 
During the acclimation period, they were fed with a 
commercial diet (Proplan; Nestle Purina Petcare, Korea) 
and tap water. To collect tissues, the dogs were euthanized 
and then the abdominal cavity was exposed by midline 
incision. The proximal duodenum, cortex of kidney and 
uterine horn were collected. All animal experimental 
procedures were approved by the Ethics Committee of the 
Chungbuk National University.
Total RNA extraction and RT-PCR
The collected duodenum, kidney and uterus were rapidly 
excised and washed in cold sterile saline (0.9% NaCl). 
Total RNA was prepared with TRIzol reagent (Invitrogen, 
USA) according to the manufacturer’s protocol and the 
RNA concentration was determined by measurement at 
260 nm. RT-PCR was performed and the obtained products 
were visualized by agarose gel electrophoresis. In brief, 
total RNA (1 μg) was reverse transcribed to first standard 
complementary DNA (cDNA) using mMLV reverse 
transcriptase (Invitrogen, USA) and random primers (9 
mers; TaKaRa Bio, Japan). CaBP-9k and glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), as a housekeeping 
gene, were amplified in a 20 μL PCR reaction containing 
1U i-StarTaq DNA polymerase (iNtRON Bio, Korea), 1.5 
mM MgCl2, 2 mM dNTP, and 20 pmol CaBP-9k- or GAPDH- 
specific primers. The oligonucleotide sequences for CaBP- 
9k were 5´-AGT CTC AAG AAC TGA AG-3´ (sense) and 
5´-AAG AGG TCA TCT AGG GTG CT-3´ (antisense). PCR 
reactions were denatured at 94
oC for 45 sec, annealed at 
58
oC for 45 sec and extended at 72
oC for 45 sec. CaBP-9k 
and GAPDH were quantified after 27 cycles. PCR products 
(10 μL) were separated on a 2% agarose gel, stained with 
ethidium bromide, and photographed under ultraviolet 
illumination. Photographs were taken using a Gel Doc EQ 
(Bio-Rad, USA).
Real-time PCR analysis
Real-time PCR was performed in 20 μL reaction volumes 
containing 10 μL of SYBR premix Ex Taq (TaKaRa Bio, 
Japan) using a 7300 Real-time PCR system (Applied Biosystems, 
USA), following the manufacturer’s recommendations. 
The oligonucleotide sequences for real-time PCR to detect 
CaBP-9k and GAPDH were identical as shown by RT-PCR. 
The relative expression levels of each gene were normalized 
to that of GAPDH and quantified using RQ software (Applied 
Biosystems, USA).
Western blot analysis
Protein was extracted using Proprep (iNtRON Bio, Korea), 
according to the manufacturer’s protocol. Protein (180 μg 
per lane) was resolved by 12% sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis and the resolved proteins 
were transferred to a polyvinylidene fluoride membrane 
(PerkinElmer Life Sciences, USA) The membrane was 
blocked 1 h with 5% bovine serum albumin (BSA) in Tris- 
buffed saline-Tween 20 (TBS-T). The membrane was 
incubated in primary antibodies diluted in 5% BSA for 5 h 
at room temperature. A 1 : 200 dilution of CaBP-9k Swant, 
Switzerland) and 1 : 500 dilution of β-Actin (Santa Cruz 
Biotechnology, USA) were used as primary antibody. A 1 
: 3,000 dilution of horseradish peroxidase-conjugated anti- 
rabbit IgG (Santa Cruz Biotechnology, USA) was used as 
secondary antibody. Immunoreactive proteins were visualized 
using Western blot detection system (West-one; iNtRON 
Bio, Korea), according to the manufacturer’s instructions. 
Signals were detected with Chemi Doc EQ (Bio-Rad, USA) 
and analyzed by Quantity One Program (Bio-Rad, USA).
Immunohistochemistry
Tissue localization of CaBP-9k protein was examined by 
immunohistochemistry. The duodenum, kidney and uterus 
tissue were individually fixed in 10% formalin overnight 
and then processed. Briefly, the tissues were dehydrated 
and embedded in paraffin, after which serial sections (7 
μm) were cut with a microtome. Sections were deparaffinized 
in xylene and hydrated in descending grades of ethanol. 
Endogenous peroxidase activity was blocked with 3% 
hydrogen peroxidase in PBS-Tween 20 for 30 min, and 
then sections were incubated in 10% normal goat serum 
(NGS) for 2 h at room temperature to block nonspecific 
binding. Sections were incubated with a 1：200 dilution of 
polyclonal rabbit antibody specific to CaBP-9k (Swant, 
Switzerland) dissolved in 10% NGS and incubated at 4
oC 
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Fig. 1. Expression of CaBP-9k mRNA (A) and relative percentage
of CaBP-9k/glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
mRNA (B) in duodenum, kidney and uterus.
Fig. 2. Expression of CaBP-9k protein in duodenum, kidney and 
uterus by Western blot analysis.
Fig. 3. Localization of CaBP-9k protein. The brush border  (arrows)
of duodenum showed positive immunoreactivities (A), while 
uterus (B) and kidney (C) showed negative immunoreactivities. 
Scale bar = 100 μm.
incubated with a 1：500 dilution of biotinylated secondary 
antibody (anti-rabbit IgG; Vector Laboratories, USA) for 
30 min at 37
oC and further incubated with ABC-Elite 
(PK-6101; Vector Laboratories, USA) for 30 min at 37
oC. 
Diaminobenzidine (Sigma-Aldrich, USA) was used as a 
chromogen, and the sections were counterstained with 
hematoxylin followed by mounting with a coverslip. 
Results
Expression of CaBP-9k mRNA in the duodenum, 
kidney and uterus
To examine the expression level of CaBP-9k mRNA, 
RT-PCR and real-time PCR were carried out. A 148 bp 
CaBP-9k transcript was observed in the canine duodenum.  
However, its expression in the kidney and uterus was 
undetectable as seen in Fig. 1. The expression of CaBP-9k 
mRNA as determined by RT-PCR (Fig. 1A) was consistent 
with the real-time PCR data expressed as a percentage of 
CaBP-9k/GAPDH mRNA (Fig. 1B). 
Expression of CaBP-9k protein in the duodenum, 
kidney and uterus
The expression of CaBP-9k protein was measured by 
Western blot analysis. In parallel with its mRNA level, the 
protein level of CaBP-9k was highly expressed in the 
duodenum, whereas its level was not detected in the canine 
kidney and uterus (Fig. 2). 
Localization of CaBP-9k protein in the duodenum
Immunohistochemistry for CaBP-9k protein in the 
duodenum revealed moderate staining along the surface of 
the villi, especially on the cytoplasm of the enterocytes, the 
major epithelial cells of the duodenal mucosa (Fig. 3).
Discussion
CaBP-9k is a small intracellular calcium-binding protein 
with two high-affinity Ca
2+ binding domains [37]. It was 
originally isolated from the rat intestine as a vitamin D- 
dependent gene and was subsequently found to be expressed 
in mammalian intestine, kidney, placenta and uterus [2,12, 
25]. The cytosolic calcium-binding proteins, CaBP-9k and 
CaBP-28k, play an important role in shuttling Ca
2+ ions 
from the apical Ca
2+ influx channels to the basolateral 
membrane [19,23], while the Na
+/Ca
2+ exchanger (NCX1) 
and plasma membrane Ca
2+-ATPase 1b function in Ca
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extrusion [31]. In the current paradigm of Ca
2+ transport, 
CaBP-9k and CaBP-28k play an essential role in intestinal 
and renal calcium (re)absorption [13]. Expression of CaBP-9k 
has been explored in most mammalians except in a canine 
model [5-7]. Thus, in this study, we elucidated the expression 
of CaBP-9k mRNA and protein in the duodenum, kidney 
and uterus in a canine model.
RT-PCR and real-time PCR analysis revealed that expression 
level of CaBP-9k mRNA was abundant in the duodenum, 
but was undetectable in the kidney and uterus of the two 
beagle dogs under the present experimental conditions. In 
parallel with its mRNA level, the expression of CaBP-9k 
protein was detected solely in the duodenum. 
There were differences in the regulation of CaBP-9k gene 
expression among different species [6,7]. For instance, 
CaBP-9k is expressed in the mouse kidney, but not in the 
rat kidney [24,32]. In parallel with the absence of CaBP-9k 
in the rat kidney, renal CaBP-9k was not observed in the 
two canines studied presently. Renal CaBP-9k is expressed 
in the distal convoluted tubule, where it is thought to 
facilitate calcium re-absorption [30]. Appropriately, we 
surmise that CaBP-9k in the kidney may be not essential 
for the proper function of this tissue, or that another and as 
yet unidentified intracellular calcium-binding protein exists. 
Although CaBP-9k was not detected in canine kidney and 
uterine tissues, other calcium-binding proteins such as 
CaBP-28k may play a role in Ca
2+ transport in these tissues.
Uterine CaBP-9k expression has been detected in most 
mammalian species, including rat [3,11], mouse [29,34], 
cow [14], pig [16] and human [27]. But its expression levels 
in the uterus considerably differ among these species by 
estrous cycle or pregnancy. For example, the expression of 
CaBP-9k in the rat uterus is not detectable at diestrus, is 
increased at proestrus and reaches its zenith at estrus, 
thereafter decreasing as animals enter metestrus [6]. In 
addition, CaBP-9k is expressed mainly in the endometrial 
stroma and myometrial of the uterus in non-pregnant rats 
[3,11], whereas in pregnant rats it is expressed in uterine 
epithelial tissue [36].
Bovine CaBP-9k is expressed only in the luminal and 
glandular epithelium of the endometrium, and not in the 
myometrium or stromal cells of the endometrium in non- 
pregnant animals [14]. Therefore, a plausible reason why 
CaBP-9k was not detected in the canine uterus in the 
present study is that the two beagle dogs were in diestrous 
period. Alternatively, the protein may be completely 
absent, akin to the baboon uterus [15]. To identify the 
localization of the CaBP-9k protein in the duodenum, 
immunohistochemistry was performed. CaBP-9k was 
localized to enterocytes, the major epithelial cells of the 
duodenal mucosa [35], especially on the cytoplasm of the 
duodenocyte and along the surface of the villi.
In summary, the present study demonstrates the expression 
of CaBP-9k in the canine duodenum, but not kidney and 
uterine tissue. Whether the function of renal and uterine 
CaBP-9k is substituted by another intracellular calcium- 
binding protein or is not essential for proper functioning of 
these tissues remains to be determined. Further study is 
also needed to determine whether alteration of the estrous 
cycle is associated with CaBP-9k expression in the canine 
uterus.
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